Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.

Novo Nordisk’s blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test.

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in ...

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...

Miramar Capital has singled out Merck (MRK), Bristol Myers Squibb (BMY), and AbbVie (ABBV ... It also acquired Aliada ...

UK Biobank has today announced the launch of the world’s most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving ...

The company is developing treatments based on a class of drug called macrocycles – compounds with a ring-like structure. While macrocycles have yielded blockbuster drugs such as the fungal-derived ...

Johnson & Johnson Innovative Medicine (J&J Innovative), formerly Janssen Pharmaceuticals, is a healthcare company that develops and supplies prescription pharmaceutical products. It offers various ...

In addition to the foreign antivirals, some pet owners also have opted for similar but cheaper Covid medicines developed by homegrown companies including Henan Genuine Biotech, Simcere Pharmaceutical ...